Montréal, Québec  October 1 - 3, 2020


The NANETS Multidisciplinary NET medical Symposium brings over 500 neuroendocrine medical professionals researchers together to discuss new diagnostic and therapeutic techniques, optimal multidisciplinary care, and the future of neuroendocrine tumor research. 


Fairmont The Queen Elizabeth
In the heart of Montreal’s thriving shopping and business district you will find Fairmont The Queen Elizabeth - a 1960s classic hotel that was transformed into a contemporary lifestyle space, complete with modern technologies and amenities.  The full completion resulted in additional suites; expanded Fairmont Gold rooms and lounge; an inspiring new business hub and meeting space; a signature bar, restaurant and urban market; a Wellness Centre and indoor pool; an outdoor terrace; and a vibrant lobby event space. We’re excited to unveil our reimagined way to do business in our city, and to share it with you! 

Address: 900 René-Lévesque Blvd W, Montreal, QC H3B 4A5, Canada

Reservation and rates will be available shortly. 

Fairmont hotel


Montréal is the largest city in Canada’s Québec province. It’s set on an island in the Saint Lawrence River and named after Mt. Royal, the triple-peaked hill at its heart. Its boroughs, many of which were once independent cities, include neighborhoods ranging from cobblestoned, French colonial Vieux-Montréal – with the Gothic Revival Notre-Dame Basilica at its centre – to bohemian Plateau.   


NANETS supports the medical community via education, research grants and scholarships to up-and-coming medical professionals responsible for advancing NET research and treatment. NANETS is also the only organization in the U.S. that offers a comprehensive education program focused on NET disease. 

In addition to making this Symposium possible, your support aids these efforts. All supporters are identified on signage in the registration area and exhibit hall entrance, acknowledged in all registration packets and through additional recognition relating to the package of choice.